ACOTEC-B (06669): Venous Intracavitary Radiofrequency Ablation System Receives FDA 510(K) Market Clearance

Stock News
2025/10/09

ACOTEC-B (06669) announced that on October 7, 2025, the company's venous intracavitary radiofrequency ablation system received 510(k) market clearance from the U.S. Food and Drug Administration. The system includes the Cedar™ venous intracavitary radiofrequency catheter and venous intracavitary radiofrequency generator, which work together to treat lower limb varicose veins caused by superficial venous reflux. The company has signed a distribution agreement with a member company of the BSC Group for the product's sales in the United States. BSC Group will commence commercialization efforts for this product in the U.S. market in due course.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10